US Patent 9884910 Anti-PDGF-C antibodies
Patent 9884910 was granted and assigned to ThromboGenics NV on February, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+281 characters)
Article
Patent abstract
The invention relates to antibodies binding to the PDGF-C antigen and capable of inhibiting binding of PDGF-C to the PDGFRα receptor and of inhibiting PDGFRα activation by PDGF-C. Applications of such antibodies are also disclosed. These include treatment of cancer.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Claudia Fromond0
Hoa Thu Ngo0
Richard Zwaal0
Sofie Notebaert0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09884910 Anti-PDGF-C antibodies US Patent 9884910 Anti-PDGF-C antibodies
Infobox
Patent Number
098849100
Patent Number
98849100
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098849100
Date of Patent
February 6, 2018
0Patent Application Number
144040520
Date Filed
April 24, 2013
0Patent Primary Examiner
Edits on 18 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09884910 Anti-PDGF-C antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09884910
Date of patent
February 6, 2018
Patent application number
14404052
Date Filed
April 24, 2013
Patent primary examiner
Find more entities like US Patent 9884910 Anti-PDGF-C antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.